Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dexter

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Journal of Neurochemistry|November 23, 2006
Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibitionSimon McArthur, Hilary E Murray, Alihusein Dhankot, et al.
Journal of Neural Transmission. General Section|January 1, 1991
(-)-Deprenyl can induce soluble superoxide dismutase in rat striataA Clow, T Hussain, V Glover, et al.
Plos Medicine|July 22, 2015
Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort StudyRuth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, et al.
NPJ Parkinson'S Disease|July 27, 2023
Neuroprotective role for RORA in Parkinson's disease revealed by analysis of post-mortem brain and a dopaminergic cell lineFelwah S Al-Zaid, Michael J Hurley, David T Dexter, et al.
Biochemical Pharmacology|July 14, 1999
Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded ratD T Dexter, R J Ward, A Florence, et al.
Annals of Neurology|January 1, 1992
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research GroupP Jenner, D T Dexter, J Sian, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1997
Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brainJ Sian, D T Dexter, G Cohen, et al.
Neuroreport|December 1, 2001
Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's diseaseK P Datla, M Christidou, W W Widmer, et al.
Journal of Neurochemistry|August 24, 2007
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivoAnthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2006
Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivoAnthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Journal of Neurochemistry|November 23, 2006
Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibitionSimon McArthur, Hilary E Murray, Alihusein Dhankot, et al.
Journal of Neural Transmission. General Section|January 1, 1991
(-)-Deprenyl can induce soluble superoxide dismutase in rat striataA Clow, T Hussain, V Glover, et al.
Plos Medicine|July 22, 2015
Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort StudyRuth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, et al.
NPJ Parkinson'S Disease|July 27, 2023
Neuroprotective role for RORA in Parkinson's disease revealed by analysis of post-mortem brain and a dopaminergic cell lineFelwah S Al-Zaid, Michael J Hurley, David T Dexter, et al.
Biochemical Pharmacology|July 14, 1999
Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded ratD T Dexter, R J Ward, A Florence, et al.
Annals of Neurology|January 1, 1992
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research GroupP Jenner, D T Dexter, J Sian, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1997
Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brainJ Sian, D T Dexter, G Cohen, et al.
Neuroreport|December 1, 2001
Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's diseaseK P Datla, M Christidou, W W Widmer, et al.
Journal of Neurochemistry|August 24, 2007
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivoAnthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2006
Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivoAnthony C Vernon, Virginia Zbarsky, Krishna P Datla, et al.
Pageof 14